Angel Todev

Dr. Angel Todev


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2024 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
OBOliana Boykinova
Oliana Boykinova
ATAngel Todev
Angel Todev
SZSimona Zlatanova
Simona Zlatanova
PVPetar Vasilev
Petar Vasilev
VTVictoria Trendafilova
Victoria Trendafilova
VKVictoria Kostadinova
Victoria Kostadinova
Chickenpox is often described as a benign disease. However, patients with varicella and coinfection with COVID-19 may develop severe respiratory infection. The interest in the presented case arose from the unusual fast progress of the chickenpox which led to a lethal outcome in a patient with unsuspected COVID-19, proven by PCR after his death. The underlying disease – cancer of the tongue was in remission and wasn’t a cause for immunosuppression which could be a reason for the clinical course of the disease. Aim: To present an interesting case of a 44-year-old man with a previous diagnosis of oral cancer who died after he was diagnosed with varicella and tested positive postmortem for COVID-19. Patient and method: A 44-year-old patient was admitted to the hospital urgently and stayed for 3 and a half hours in the clinic of infectious diseases of UMHAT "St. George", Plovdiv, with a diagnosis of varicella. The patient has accompanying diseases like oral cancer (root of the tongue) and hypertension. Epidemiological data are for contact and fresh infection with varicella, progressing rapidly and beginning of symptoms of respiratory insufficiency and lethal outcome. Due to the fulminant course and the short period of time, the positive PCR result for COVID-19 was proved after the patient died. Conclusions: Unsuspected comorbidity of COVID-19 and varicella without any other reason for immunosuppression could induce unusual severe course of the chickenpox.

15 August 2025 in Immuno
Verified
Journal Article
Open access
PDF file
SPSteliyan Petrov
Steliyan Petrov
MBMartina Bozhkova
Martina Bozhkova
Mariya IvanovskaMariya Ivanovska
Mariya Ivanovska
TKTeodora Kalfova
Teodora Kalfova
ABAlexandra Baldzhieva
Alexandra Baldzhieva
HTHristo Taskov
Hristo Taskov
The immune response to SARS-CoV-2 infection involves significant alterations in the phenotype and function of natural killer (NK) cells. This study aimed to investigate the dynamic changes in NK cell subsets during COVID-19 by analyzing their activation and inhibitory markers [CD3, CD14, CD16, CD19, CD25, CD45, CD56, CD57, CD69, CD159a (NKG2A), CD159c (NKG2C), CD314 (NKG2D), CD335 (NKp46)], cytotoxic potential (perforin, interferon-gamma, granzyme B), and direct cytotoxicity against a newly genetically modified K562 cell line. Peripheral blood samples were collected from COVID-19 patients on days 3–5 and day 30 post-symptom onset and were compared to healthy controls. 16-color flow cytometry analysis revealed distinct shifts in NK cell subpopulations, characterized by increased expression of the inhibitory receptor NKG2A and the activating receptors NKG2D and NKG2C, particularly in the CD56+CD16− subset. Elevated IFN-γ production on day 30 suggested a recovery-phase immune response, while the persistent upregulation of NKG2A indicated an ongoing regulatory mechanism. The CD16+CD56− subpopulation exhibited increased expression of the markers CD69 and CD25 over time; however, its cytotoxic potential, assessed through granzyme B levels and direct cytotoxicity assays, remained lower than that of healthy controls. Significant correlations were observed between CD57 and CD69 expression, as well as NKp46 and IFN-γ production, highlighting a coordinated balance between activation and regulatory mechanisms. These findings suggest that NK cells undergo functional adaptation during COVID-19, displaying signs of partial exhaustion while retaining antiviral potential. Understanding the interplay between NK cell activation and suppression may provide valuable insights into immune dysregulation in COVID-19 and inform potential therapeutic interventions.